Inclisiran for Participants With Atherosclerotic Cardiovascular Disease and Elevated Low-density Lipoprotein Cholesterol
Clinical trial NCT03399370 · COMPLETED
Trial details
- NCT number
- NCT03399370
- Sponsor
- The Medicines Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-21
- Primary completion
- 2019-09-10
- Enrollment
- 1561
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.